Get startedLog in
    Picture of Egetis Therapeutics AB (publ) logo

    EGTX — Egetis Therapeutics AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapMomentum Trap
    All News

    Brief: PledPharma Presents Results From Study On Aladote For Paracetamol Poisoning

    Picture of Egetis Therapeutics AB (publ) logoEgetis Therapeutics AB (publ)
    13/12/2018 07:09
    Dec 13 (Reuters) - PledPharma AB (publ)  PLED.ST :
    * REG-PLEDPHARMA PRESENTS RESULTS FROM STUDY ON DRUG
CANDIDATE
ALADOTE® FOR PARACETAMOL POISONING AT A GLOBAL TOXICOLOGY
CONFERENCE
    * RESULTS SHOWED THAT ALADOTE(®) IS SAFE AND TOLERABLE WHEN
GIVEN
TOGETHER WITH NAC
    * PLEDPHARMA - RESULTS ALSO INDICATE THAT ALADOTE CAN REDUCE
LIVER
DAMAGE IN CURRENT PATIENT POPULATION BASED ON ANALYSES OF
PREDEFINED EXPLORATORY BIOMARKERS KERATIN-18 (K18) AND
MICRORNA-122 (MIR-122) IN BLOOD SAMPLES

Source text for Eikon:  ID:nGNE1ClhW7 
Further company coverage:  PLED.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

    Recent news on Egetis Therapeutics AB (publ)

    See all news